Weida Liang

Dr. Weida Liang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
XCXinpei Cai
Xinpei Cai
WLWeida Liang
Weida Liang
MLMingxin Liu
Mingxin Liu
XLXiating Li
Xiating Li
MDMingji Dai
Mingji Dai

3 January 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Xiao WangXiao Wang
Xiao Wang
HQHongda Qiu
Hongda Qiu
NYNa Yang
Na Yang
HXHaoji Xie
Haoji Xie
WLWeida Liang
Weida Liang
Hongze LiangHongze Liang
Hongze Liang

27 December 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
LLLei Li
Lei Li
WLWeida Liang
Weida Liang
MRMario E. Rivera
Mario E. Rivera
YWYe-Cheng Wang
Ye-Cheng Wang
MDMingji Dai
Mingji Dai

14 July 2022 in ChemistrySelect
Verified
Journal Article
Closed access
YJYinli Jiang
Yinli Jiang
HQHongda Qiu
Hongda Qiu
WLWeida Liang
Weida Liang
JLJunhao Lin
Junhao Lin
JLJiayu Lin
Jiayu Lin
Hongze LiangHongze Liang
Hongze Liang

21 April 2025 in Materials
Verified
Journal Article
Open access
PDF file
XLXinyu Liu
Xinyu Liu
XZXing Zhao
Xing Zhao
HQHongda Qiu
Hongda Qiu
WLWeida Liang
Weida Liang
LLLinlin Liu
Linlin Liu
Hongze LiangHongze Liang
Hongze Liang
The development of antibiotic-independent antimicrobial materials is critical for addressing bacterial resistance to conventional antibiotics. Currently, there is a lack of comprehensive understanding of ionic liquid-modified composites in antimicrobial applications. Here, we innovatively prepared GO-based composites modified with phosphonate ionic liquids via a series of surface functionalizations. The resulting antibacterial composites exhibit significant broad-spectrum activity against both Gram-negative and Gram-positive bacteria, including drug-resistant strains, with stronger efficacy against Gram-negative species. Additionally, the material features excellent long-term reusability and the ability to inhibit/destroy biofilms, which is vital for combating persistent infections. Mechanistic studies reveal its antibacterial effects through multiple pathways: disrupting bacterial membranes, inducing ROS, and inactivating intracellular substances—mechanisms less likely to promote resistance. Overall, these phosphonate ionic liquid-modified polycationic materials demonstrate substantial potential in treating bacterial infections, offering a promising strategy to tackle antibiotic resistance challenges.

18 June 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
LLLinlin Liu
Linlin Liu
ZCZhenhua Chen
Zhenhua Chen
DWDanni Wang
Danni Wang
WLWeida Liang
Weida Liang
BWBinbin Wang
Binbin Wang
Hongze LiangHongze Liang
Hongze Liang
Protein phosphorylation is one of the most common and important post-translational modifications (PTMs) and is highly involved in various biological processes. Ideal adsorbents with high sensitivity and specificity toward phosphopeptides with large coverage are therefore essential for enrichment and mass spectroscopy-based phosphoproteomics analysis. In this study, a newly designed IMAC adsorbent composite was constructed on the graphene matrix coated with mesoporous silica. The outer functional 3D-network layer was prepared by free radical polymerization of the phosphonate-functionalized vinyl imidazolium salt monomer and subsequent metal immobilization. Due to its unique structural feature and high content of Ti4+ ions, the resulting phosphonate-immobilized adsorbent composite G@mSiO2@PPFIL-Ti4+ exhibits excellent performance in phosphopeptide enrichment with a low detection limit (0.1 fmol, tryptic β-casein digest) and superior selectivity (molar ratio of 1:15,000, digest mixture of β-casein and bovine serum albumin). G@mSiO2@PPFIL-Ti4+ displays high tolerance to loading and elution conditions and thus can be reused without a marked decrease in enrichment efficacy. The captured phosphopeptides can be released globally, and mono-/multi-phosphopeptides can be isolated stepwise by gradient elution. When applying this material to enrich phosphopeptides from human lung cell lysates, a total of 3268 unique phosphopeptides were identified, corresponding to 1293 phosphoproteins. Furthermore, 2698 phosphorylated peptides were found to be differentially expressed (p < 0.05) between human lung adenocarcinoma cells (SPC-A1) and human normal epithelial cells (Beas-2B), of which 1592 were upregulated and 1106 were downregulated in the cancer group. These results demonstrate the material’s superior enrichment efficiency in complex biological samples.